Silvercrest Asset Management’s St Jude Medical STJ Stock Holding History

Silvercrest Asset Management’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,154	Closed	-$333K	–	597
2016 Q4	$333K	Sell	4,154 -496	-11%	-$39.4K	﹤0.01%	468
2016 Q3	$371K	Sell	4,650 -500	-10%	-$40.4K	﹤0.01%	447
2016 Q2	$402K	Hold	5,150	–	–	0.01%	433
2016 Q1	$283K	Hold	5,150	–	–	﹤0.01%	471
2015 Q4	$318K	Sell	5,150 -5,000	-49%	-$315K	﹤0.01%	475
2015 Q3	$640K	Hold	10,150	–	–	0.01%	358
2015 Q2	$742K	Buy	10,150 +1,000	+11%	+$72.2K	0.01%	364
2015 Q1	$598K	Sell	9,150 -200	-2%	-$13.3K	0.01%	361
2014 Q4	$608K	Buy	+9,350	New	+$602K	0.01%	348
2014 Q3	–	Sell	-3,350	Closed	-$232K	–	478
2014 Q2	$232K	Hold	3,350	–	–	﹤0.01%	440
2014 Q1	$219K	Hold	3,350	–	–	﹤0.01%	435
2013 Q4	$208K	Buy	+3,350	New	+$194K	﹤0.01%	440

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Silvercrest Asset Management's STJ Position: Q1 2017 in Review

Silvercrest Asset Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 4,154 shares — an estimated $333K sold.

Silvercrest Asset Management first reported a position in STJ in Q4 2013 and held it in 12 quarters. The position peaked at $742K in Q2 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Silvercrest Asset Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Silvercrest Asset Management sold 4,154 St Jude Medical shares in Q1 2017, an estimated $333K.
Silvercrest Asset Management first reported a position in St Jude Medical in Q4 2013 and held it in 12 quarters.
Silvercrest Asset Management's St Jude Medical position peaked at $742K in Q2 2015.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Silvercrest Asset Management's 13F filing for Q1 2017, filed 15 May 2017.